Abdelmarouf Mohieldein
About
In The Last Decade
Abdelmarouf Mohieldein
25 papers receiving 334 citations
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 93
- Molecular Biology 51
- Epidemiology 49
- Food Science 49
- Public Health, Environmental and Occupational Health 34
Countries citing papers authored by Abdelmarouf Mohieldein
This map shows the geographic impact of Abdelmarouf Mohieldein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdelmarouf Mohieldein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdelmarouf Mohieldein more than expected).
Fields of papers citing papers by Abdelmarouf Mohieldein
This network shows the impact of papers produced by Abdelmarouf Mohieldein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdelmarouf Mohieldein. The network helps show where Abdelmarouf Mohieldein may publish in the future.
Co-authorship network of co-authors of Abdelmarouf Mohieldein
This figure shows the co-authorship network connecting the top 25 collaborators of Abdelmarouf Mohieldein. A scholar is included among the top collaborators of Abdelmarouf Mohieldein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdelmarouf Mohieldein. Abdelmarouf Mohieldein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | Diabetic type 2 and breast cancer marker CA 15.3 value | 2 |
| 11 | 6 | |
| 12 | 25 | |
| 13 | Comparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases | 116 |
| 14 | Dyslipidemia and lipid peroxidation of Saudi type 2 diabetics with proliferative retinopathy. | 12 |
| 15 | 28 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 7 | |
| 19 | 32 | |
| 20 | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.